期刊文献+

磷脂酰肌醇蛋白多糖-3在肝细胞癌中的特异性和敏感性以及表达 被引量:2

Specificity and sensitivity and expression of glypican-3 in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨磷脂酰肌醇蛋白多糖-3(glypican-3,GPC3)在高、中/低分化的肝细胞癌(hepatocellular carcinoma,HCC)组中的表达强度、特异性和敏感性。方法挑选首都医科大学附属北京佑安医院2009年12月至2010年9月收治的肝细胞癌病例70例,经过免疫组化染色,观察GPC3在肝细胞癌内以及其周围非肝细胞癌的着色情况和GPC3在所有肝细胞癌病例中的检出率。将70个病例根据癌分化程度分为高、中/低两组。观察GPC3在两组中的着色强度与Ki67在两组中的表达强度是否有相关性。结果①所有肝细胞癌病例的GPC3染色只在肝细胞癌中,肝细胞癌周围非癌组织中均不着色;GPC3在高、中/低两组中总检出率为85%,高分化组中阳性率73.0%,中/低分化组阳性检出率90.2%。②GPC3中强着色度(++、+++)在高分化组中只有2例,占10.5%;在中/低分化组中38例,占74.8%。GPC3在高,中/低分化的肝细胞癌中的表达强度差异有统计学意义(P<0.01)。③Ki67在高分化组中(++、+++)中强度表达是0例,占0%;在中/低分化组中中强度表达是37例,占72.5%,Ki67在高、中/低分化组肝细胞癌中的表达差异有统计学意义(P<0.01)。GPC3在这两组中的着色强度和Ki67在这2组中的的表达强度具有相关性(P<0.01)。结论 GPC3在肝细胞癌中的表达具有高度特异性和敏感性,对肝细胞癌诊断有重要价值。 Objective To investigate specificity,sensitivity and expression of glypican-3(GPC3) in well differentiated,moderately or poorly differentiated hepatocellular carcinoma(HCC) groups Methods Seventy cases with HCC were chosen from our hospital from Dec.2009 to Sep.2010.Expression of GPC3 in HCC as well as in non-HCC surrounding tissue was observed by immunohistochemical-staining and detection rate of GPC3 was calculated.Seventy cases were divided into two groups,well differentiated and moderately/poorly differentiated groups.Correlation between GPC3 and Ki67 were analyzed in two groups.Results ① Staining for GPC3 was positive only in HCC tissues,and was negative in non-HCC surrounding tissue of HCC.Detection rate of GPC3 was 85% in two groups,positive rate 73% in the well differentiated group,90% in the moderately/poorly differentiated group.② Staining intensity was middle/strong for GPC3 in two cases,accounting for 10% in the well differentiated group,38 cases(74.8%) in the mediately/ poorly differentiated group.Expression of GPC3 was significantly different in well differentiated group and moderately/poorly differentiated group(P0.01).③ In none of the cases the expression level of the Ki67 was moderate and strong(+ +,+ + +).In 37 cases(72%) of the moderately/poorly differentiated group,the expression was moderately strong.Expression of Ki67 was significantly different in well,moderately/poorly differentiated group(P0.01).Staining intensity of GPC3 was correlated with expression of Ki67(P0.01).Conclusion Expression of GPC3 is of the high degree of specificity and sensitivity in HCC.GPC3 may have important value in pathological diagnosis of HCC.
出处 《首都医科大学学报》 CAS 北大核心 2011年第4期545-548,共4页 Journal of Capital Medical University
基金 首都医科大学临床-基础基金(09JL04)~~
关键词 肝细胞癌 分化程度 特异性 敏感性 磷脂酰肌醇蛋白多糖-3 KI67 hepatocellular carcinoma differentiation specificity sensitivity glypican-3 Ki67
  • 相关文献

参考文献8

  • 1罗飞兵,张焜和.Glypican-3与原发性肝癌关系研究进展[J].世界华人消化杂志,2010,18(2):155-159. 被引量:6
  • 2Shirakawa H, Suzuki H, Shimomura M, et al. Glypican-3 expression is correlated with poor prognosis inhepatocellular carcinoma[J]. Cancer Sci, 2009,100(8):1403-1407.
  • 3丁光辉,王红阳,陈汉,吴孟超,满晓波,丛文铭,杨家和,程树群,李楠,沈丽.Expression of the Glypican-3 Gene in α-fetoprotein-negative Human Hepatocellular Carcinoma[J].The Chinese-German Journal of Clinical Oncology,2005,4(5):262-266. 被引量:1
  • 4Llovet J M, Chen Y, Wurmbach E, et al. A molecularsignature to discriminate dysplastic nodules fromearly hepatocellular carcinoma in HCV cirrhosis[J]. Gastroenterology, 2006,131(6):1758-1767.
  • 5Di Tommaso L, Franchi G, Park Y N, et al. Diagnostic value of HSP70, glypican3, and glutamine synthetaseinhepatocellularnodules in cirrhosis[J]. Hepatology, 2007,45(3):725-734.
  • 6ChengLiao,Mu-junZhao,JingZhao,HaiSong,PascalPineau,AgnésMarchio,AnneDejean,PierreTiollais,Hong-YangWang,Tsai-PingLi.Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma[J].World Journal of Gastroenterology,2003,9(1):89-93. 被引量:67
  • 7Wang H L, Anatelli F, Zhai Q J, et al. Glypican-3 as a useful diagnostic markerthat distinguishes hepatocellular carcinoma frombenign hepatocellular mass lesions[J]. Arch Pathol Lab Med, 2008,132(11):1723-1728.
  • 8Abdul-Al H M, Makhlouf H R, Wang G, et al. Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma[J]. Hum Pathol, 2008,39(2):209-212.

二级参考文献39

  • 1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 2Xiu-Sheng He Qi Su Zhu-Chu Chen Xiu-Tao He Zhi-Feng Long Hui Ling Liang-Run Zhang Oncology Institute,Nanhua University,Hengyang 421001,Hunan Province,ChinaOncology Institute,Center South University,Changsha 410078,Hunan Province,China Department of Gastroenterology,First People’s Hospital of Changde City,Changde 415003,Hunan Province,China.Expression,deleton and mnutation of ρ16 gene in human gastric cancer[J].World Journal of Gastroenterology,2001,7(4):515-521. 被引量:40
  • 3PENG Xiao Mou, YAO Chun Lan, CHEN Xue Juan, PENG Wen Wei and GAO Zhi Liang.Codon 249 mutations of p53 gene in non-neoplastic liver tissues[J].World Journal of Gastroenterology,1999,5(4):52-54. 被引量:11
  • 4Filmus J, Capurro M. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol Diagn 2004; 8: 207-212.
  • 5Shirakawa H, Suzuki H, Shimomura M, Kojima M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, Kinoshita T, Nakatsura T. Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma. Cancer Sci 2009; 100: 1403-1407.
  • 6Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 1996; 12:241-247.
  • 7Lapunzina P. Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am ] Med Genet C Semin Med Genet 2005; 137C: 53-71.
  • 8Liu B, Paranjpe S, Bowen WC, Bell AW, Luo JH, Yu YP, Mars WM, Michalopoulos GK. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Am J Pathol 2009; 175: 717-724.
  • 9Lai JP, Sandhu DS, Yu C, Han T, Moser CD, Jackson KK, Guerrero RB, Aderca I, Isomoto H, Garrity- Park MM, Zou H, Shire AM, Nagorney DM, Sanderson SO, Adjei AA, Lee JS, Thorgeirsson SS, Roberts LR. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology 2008; 47:1211-1222.
  • 10Morford LA, Davis C, Jin L, Dobierzewska A, Peterson ML, Spear BT. The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2. Hepatology 2007; 46: 1541-1547.

共引文献71

同被引文献15

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部